Ariel Investments, LLC Novo Nordisk A S Transaction History

Ariel Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $394,929 - $482,252	-4,119 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$67.06 - $75.82 $29,036 - $32,830	-433 Reduced 9.51%	4,119 $278,000
Q3 2020 Nov 13, 2020	BUY	$63.69 - $70.22 $3,184 - $3,511	50 Added 1.11%	4,552 $316,000
Q2 2020 Aug 14, 2020	BUY	$58.54 - $67.94 $263,547 - $305,865	4,502 New	4,502 $295,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Ariel Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Ariel Investments, LLC with notifications on news.